Genetic Testing for Maturity-Onset Diabetes of the Young

Genetic Testing for Maturity-Onset Diabetes of the Young

Conclusions

A molecular diagnosis of monogenic diabetes alters management and identifies affected and at-risk family members. Thus, genetic testing should be pursued in all patients meeting a clinical diagnosis of maturity-onset diabetes of the young. Moreover, such patients should be followed longitudinally through registries to facilitate our understanding of the unique features and best treatment of each genetic cause of maturity-onset diabetes of the young. Patients with suspected and confirmed diagnoses of monogenic diabetes can be directed to our website at http://www.monogenicdiabetesregistry.org to consider participation in our IRB-approved studies of monogenic diabetes.